Literature DB >> 23958922

Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia.

P Musto1, V Simeon2, M C Martorelli3, M T Petrucci4, N Cascavilla5, F Di Raimondo6, T Caravita7, F Morabito8, M Offidani9, A Olivieri10, G Benevolo11, R Mina12, R Guariglia3, G D'Arena3, G Mansueto3, N Filardi13, F Nobile14, A Levi4, A Falcone5, M Cavalli6, G Pietrantuono3, O Villani3, S Bringhen12, P Omedè12, R Lerose15, L Agnelli16, K Todoerti2, A Neri16, M Boccadoro12, A Palumbo12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23958922     DOI： 10.1038/leu.2013.241

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

Review 1.  Primary plasma cell leukemia: report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature.

Authors:  Steven Saccaro; Rafael Fonseca; Diana M Veillon; James Cotelingam; Mary L Nordberg; Christopher Bredeson; Jonathan Glass; Reinhold Munker
Journal:  Am J Hematol       Date:  2005-04       Impact factor: 10.047

2.  Clinical outcomes of patients with plasma cell leukemia in the era of novel therapies and hematopoietic stem cell transplantation strategies: a single-institution experience.

Authors:  Daniel Lebovic; Ling Zhang; Melissa Alsina; Taiga Nishihori; Kenneth H Shain; Daniel Sullivan; Jose L Ochoa-Bayona; Mohamed A Kharfan-Dabaja; Rachid Baz
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2011-08-02

3.  Salvage therapy with lenalidomide and dexamethasone in relapsed primary plasma cell leukemia.

Authors:  Pellegrino Musto; Giuseppe Pietrantuono; Roberto Guariglia; Oreste Villani; Maria Carmen Martorelli; Fiorella D'Auria; Antonia Zonno; Rosa Lerose
Journal:  Leuk Res       Date:  2008-04-22       Impact factor: 3.156

4.  Primary plasma cell leukemia and autologous stem cell transplantation.

Authors:  Mary B Drake; Simona Iacobelli; Anja van Biezen; Curly Morris; Jane F Apperley; Dietger Niederwieser; Bo Björkstrand; Gösta Gahrton
Journal:  Haematologica       Date:  2010-05       Impact factor: 9.941

5.  Primary plasma cell leukemia: a retrospective multicenter study of 73 patients.

Authors:  L Pagano; C G Valentini; V De Stefano; A Venditti; G Visani; M T Petrucci; A Candoni; G Specchia; C Visco; E M Pogliani; F Ferrara; P Galieni; A Gozzetti; L Fianchi; M De Muro; G Leone; P Musto; A Pulsoni
Journal:  Ann Oncol       Date:  2011-01-20       Impact factor: 32.976

6.  Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome.

Authors:  Katia Todoerti; Luca Agnelli; Sonia Fabris; Marta Lionetti; Giacomo Tuana; Laura Mosca; Luigia Lombardi; Vitina Grieco; Gabriella Bianchino; Fiorella D'Auria; Teodora Statuto; Carmela Mazzoccoli; Luciana De Luca; Maria Teresa Petrucci; Fortunato Morabito; Massimo Offidani; Francesco Di Raimondo; Antonietta Falcone; Paola Omede'; Pierfrancesco Tassone; Mario Boccadoro; Antonio Palumbo; Antonino Neri; Pellegrino Musto
Journal:  Clin Cancer Res       Date:  2013-04-18       Impact factor: 12.531

Review 7.  Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.

Authors:  C Fernández de Larrea; R A Kyle; B G M Durie; H Ludwig; S Usmani; D H Vesole; R Hajek; J F San Miguel; O Sezer; P Sonneveld; S K Kumar; A Mahindra; R Comenzo; A Palumbo; A Mazumber; K C Anderson; P G Richardson; A Z Badros; J Caers; M Cavo; X LeLeu; M A Dimopoulos; C S Chim; R Schots; A Noeul; D Fantl; U-H Mellqvist; O Landgren; A Chanan-Khan; P Moreau; R Fonseca; G Merlini; J J Lahuerta; J Bladé; R Z Orlowski; J J Shah
Journal:  Leukemia       Date:  2012-11-21       Impact factor: 11.528

8.  Efficacy and safety of bortezomib in patients with plasma cell leukemia.

Authors:  Pellegrino Musto; Fausto Rossini; Francesca Gay; Vincenzo Pitini; Tommasina Guglielmelli; Giovanni D'Arena; Felicetto Ferrara; Nunzio Filardi; Roberto Guariglia; Antonio Palumbo
Journal:  Cancer       Date:  2007-06-01       Impact factor: 6.860

9.  Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols.

Authors:  S Z Usmani; B Nair; P Qu; E Hansen; Q Zhang; N Petty; S Waheed; J D Shaughnessy; Y Alsayed; C J Heuck; F van Rhee; T Milner; A Hoering; J Szymonifka; R Sexton; J Sawyer; Z Singh; J Crowley; B Barlogie
Journal:  Leukemia       Date:  2012-04-17       Impact factor: 11.528

10.  Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research.

Authors:  A Mahindra; M E Kalaycio; J Vela-Ojeda; D H Vesole; M-J Zhang; P Li; J R Berenson; J M Bird; A Dispenzieri; J L Gajewski; R P Gale; L Holmberg; S Kumar; R A Kyle; H M Lazarus; S Lonial; J Mikhael; G A Milone; R Munker; R Nath; S Saccaro; L Bik To; D T Vogl; B Wirk; P Hari
Journal:  Leukemia       Date:  2011-11-01       Impact factor: 11.528
View more
  28 in total

1.  Trends in survival of patients with primary plasma cell leukemia: a population-based analysis.

Authors:  Wilson I Gonsalves; S Vincent Rajkumar; Ronald S Go; Angela Dispenzieri; Vinay Gupta; Preet P Singh; Francis K Buadi; Martha Q Lacy; Prashant Kapoor; David Dingli; John A Lust; Steven R Zeldenrust; Suzanne R Hayman; Robert A Kyle; Morie A Gertz; Shaji K Kumar
Journal:  Blood       Date:  2014-06-23       Impact factor: 22.113

Review 2.  Extramedullary multiple myeloma.

Authors:  Manisha Bhutani; David M Foureau; Shebli Atrash; Peter M Voorhees; Saad Z Usmani
Journal:  Leukemia       Date:  2019-11-27       Impact factor: 11.528

3.  Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia.

Authors:  Laura A Evans; Dragan Jevremovic; Bharat Nandakumar; Angela Dispenzieri; Francis K Buadi; David Dingli; Martha Q Lacy; Suzanne R Hayman; Prashant Kapoor; Nelson Leung; Amie Fonder; Miriam Hobbs; Yi Lisa Hwa; Eli Muchtar; Rahma Warsame; Taxiarchis V Kourelis; Ronald Go; Stephen Russell; John A Lust; Yi Lin; Mustaqeem Siddiqui; Robert A Kyle; Morie A Gertz; S Vincent Rajkumar; Shaji K Kumar; Wilson I Gonsalves
Journal:  Am J Hematol       Date:  2020-03-26       Impact factor: 10.047

Review 4.  Primary Plasma Cell Leukemia: Identity Card 2016.

Authors:  Pellegrino Musto; Vittorio Simeon; Katia Todoerti; Antonino Neri
Journal:  Curr Treat Options Oncol       Date:  2016-04

5.  Whole-exome sequencing of primary plasma cell leukemia discloses heterogeneous mutational patterns.

Authors:  Ingrid Cifola; Marta Lionetti; Eva Pinatel; Katia Todoerti; Eleonora Mangano; Alessandro Pietrelli; Sonia Fabris; Laura Mosca; Vittorio Simeon; Maria Teresa Petrucci; Fortunato Morabito; Massimo Offidani; Francesco Di Raimondo; Antonietta Falcone; Tommaso Caravita; Cristina Battaglia; Gianluca De Bellis; Antonio Palumbo; Pellegrino Musto; Antonino Neri
Journal:  Oncotarget       Date:  2015-07-10

6.  Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation.

Authors:  Marta Lionetti; Marzia Barbieri; Katia Todoerti; Luca Agnelli; Simona Marzorati; Sonia Fabris; Gabriella Ciceri; Serena Galletti; Giulia Milesi; Martina Manzoni; Mara Mazzoni; Angela Greco; Giovanni Tonon; Pellegrino Musto; Luca Baldini; Antonino Neri
Journal:  Oncotarget       Date:  2015-09-15

7.  Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature.

Authors:  Marta Lionetti; Marzia Barbieri; Martina Manzoni; Sonia Fabris; Cecilia Bandini; Katia Todoerti; Filomena Nozza; Davide Rossi; Pellegrino Musto; Luca Baldini; Antonino Neri
Journal:  Oncotarget       Date:  2016-04-19

Review 8.  Practical management and assessment of primary plasma cell leukemia in the novel agent era.

Authors:  A Visram; A Suska; A Jurczyszyn; W I Gonsalves
Journal:  Cancer Treat Res Commun       Date:  2021-06-08

Review 9.  Molecular Classification and Pharmacogenetics of Primary Plasma Cell Leukemia: An Initial Approach toward Precision Medicine.

Authors:  Vittorio Simeon; Katia Todoerti; Francesco La Rocca; Antonella Caivano; Stefania Trino; Marta Lionetti; Luca Agnelli; Luciana De Luca; Ilaria Laurenzana; Antonino Neri; Pellegrino Musto
Journal:  Int J Mol Sci       Date:  2015-07-30       Impact factor: 5.923

10.  A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias.

Authors:  Marta Lionetti; Marzia Barbieri; Katia Todoerti; Luca Agnelli; Sonia Fabris; Giovanni Tonon; Simona Segalla; Ingrid Cifola; Eva Pinatel; Pierfrancesco Tassone; Pellegrino Musto; Luca Baldini; Antonino Neri
Journal:  Oncotarget       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.